Top Section/Bond comments/Ad
Top Section/Bond comments/Ad
Most recent
◆ Issuer leaves concession on the table to secure top accounts ◆ Pricing versus AFD deal ◆ Official institutions hold French agency spreads at the tights
◆ Sven Wabbels reveals four dimensions behind dual tranche call ◆ Seven year restraint as 1bp for four years more risk ◆ Pricing through Treasuries 'not a goal'
◆ Debut seven year priced through issuer's dollar curve, leads say ◆ Green label and no-grow size steady IFC through selloff ◆ Rival banker questions wisdom of July inaugural
◆ Steep government curve means investors need less spread on top ◆ French spreads widen, but AFD tightens ◆ Fair value 'a fluid concept' on inverted curve
More articles/Ad
More articles/Ad
More articles
-
The Swiss franc market is having a busy year, with a strong showing from corporate and SSA issuers helping the market to its highest year to date volume since 2015, according to Dealogic. -
Euro investors are sniffing around further out along the SSA curve, with Euratom returning after a two year absence to print a 10 year bond earmarked to fund power plant safety measures in Ukraine, while the Treasury Corp of Victoria tapped demand past the 30 year point.
-
Swedish Export Credit Corporation kept the public sector new issues market open on Thursday as it came with an opportunistic four year dollar trade on the back of a strong week for dollar borrowers.
-
The European Stability Mechanism is likely to use its funding window scheduled for next week to issue a dollar benchmark, according to SSA bankers.
-
The International Finance Facility for Immunisation (IFFIm) was set up in 2006 to provide funding to Gavi, the Vaccine Alliance, itself a public/private sector partnership, to expedite the vaccination of children in the poorest countries against endemic infectious diseases. Doris Herrera-Pol, IFFIm board member and former director of global capital markets at the World Bank, spoke to GlobalCapital about the role the capital markets can play in the development and deployment of a Covid-19 vaccine.
-
The euro SSA market has grown used to investors flush with cash, itching to buy anything that comes on screens with a good enough rating. But with the EU preparing to issue more than €850bn over the next few years, the balance will shift against issuers, and they must be prepared.
